Cargando…

Salidroside Improves Bone Histomorphology and Prevents Bone Loss in Ovariectomized Diabetic Rats by Upregulating the OPG/RANKL Ratio

Postmenopausal diabetic women have a high risk of fractures. Salidroside has preventive effects on estrogen deficiency-induced osteoporosis and has hypoglycemic effects on diabetes in rats. However, whether salidroside inhibits bone loss in postmenopausal diabetic patients is still unknown. Here, we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Hongxing, Qi, Shanshan, Chen, Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225177/ https://www.ncbi.nlm.nih.gov/pubmed/30235836 http://dx.doi.org/10.3390/molecules23092398

Ejemplares similares

High-Dose Diosgenin Reduces Bone Loss in Ovariectomized Rats via Attenuation of the RANKL/OPG Ratio
por: Zhang, Zhiguo, et al.
Publicado: (2014)

Effect of enhanced masticatory force on OPG, RANKL and MGF in alveolar bone of ovariectomized rats
por: Ma, Zongmin, et al.
Publicado: (2020)

Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children
por: Wasilewska, Anna, et al.
Publicado: (2010)

Tetrandrine Prevents Bone Loss in Ovariectomized Mice by Inhibiting RANKL-Induced Osteoclastogenesis
por: Zhong, Zeyuan, et al.
Publicado: (2020)

Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis
por: Chen, Xiao, et al.
Publicado: (2017)

Fuscoside Attenuates Bone Loss in Bone Defects by Regulating The Rankl/Nlrp3/Opg Pathway in Rats
por: Liu, Xiangwei, et al.
Publicado: (2021)

Astilbin prevents bone loss in ovariectomized mice through the inhibition of RANKL‐induced osteoclastogenesis
por: Jin, Haiming, et al.
Publicado: (2019)

Substance P participates in periodontitis by upregulating HIF-1α and RANKL/OPG ratio
por: Yan, Kaixian, et al.
Publicado: (2020)

Biology of the RANKL–RANK–OPG System in Immunity, Bone, and Beyond
por: Walsh, Matthew C., et al.
Publicado: (2014)

Bone Metabolism and RANKL/OPG Ratio in Rheumatoid Arthritis Women Treated with TNF-α Inhibitors
por: Jura-Półtorak, Agnieszka, et al.
Publicado: (2021)

The effect of vitamin D deficiency on the RANKL/OPG ratio in rats
por: Khalaf, Rawan M., et al.
Publicado: (2022)

Bone mineral density in egyptian children with juvenile idiopathic arthritis: possible correlation to serum RANKL / osteoprotegerin (OPG) ratio and OPG gene polymorphisms
por: Eid, Riham, et al.
Publicado: (2023)

Soy Isoflavones and Bone Health: Focus on the RANKL/RANK/OPG Pathway
por: Hooshiar, Saeedeh Hosseini, et al.
Publicado: (2022)

Serum levels of RANKL and OPG, and the RANKL/OPG ratio in bisphosphonate-related osteonecrosis of the jaw: Are they useful biomarkers for the advanced stages of osteonecrosis?
por: Bagan, Leticia, et al.
Publicado: (2017)

Dysregulated B Cell Expression of RANKL and OPG Correlates with Loss of Bone Mineral Density in HIV Infection
por: Titanji, Kehmia, et al.
Publicado: (2014)

Impact of periodontal treatment on the RANKL/OPG ratio in crevicular fluid
por: López Roldán, Andrés, et al.
Publicado: (2020)

RANKL/OPG ratio regulates odontoclastogenesis in damaged dental pulp
por: Nishida, Daisuke, et al.
Publicado: (2021)

PRMT1 mediates RANKL-induced osteoclastogenesis and contributes to bone loss in ovariectomized mice
por: Choi, Joo-Hee, et al.
Publicado: (2018)

Association between low bone mass and the serum RANKL and OPG in patients with nephrolithiasis
por: Mansour, Asieh, et al.
Publicado: (2018)

Effect of sumac extract on serum oxidative status, RANKL/OPG system and alveolar bone loss in experimental periodontitis in rats
por: SAĞLAM, Mehmet, et al.
Publicado: (2015)

Therapeutic effect of Shinkiwhan, herbal medicine, regulates OPG/RANKL/RANK system on ovariectomy-induced bone loss rat
por: Seo, Il-bok, et al.
Publicado: (2020)

S-Equol enhances osteoblastic bone formation and prevents bone loss through OPG/RANKL via the PI3K/Akt pathway in streptozotocin-induced diabetic rats
por: Xu, Zhe, et al.
Publicado: (2022)

Adiponectin regulates bone mass in AIS osteopenia via RANKL/OPG and IL6 pathway
por: Zhang, Hong-qi, et al.
Publicado: (2019)

Propofol attenuates osteoclastogenesis by lowering RANKL/OPG ratio in mouse osteoblasts
por: Lee, Do-Won, et al.
Publicado: (2018)

Nitazoxanide, an Antiprotozoal Drug, Reduces Bone Loss in Ovariectomized Mice by Inhibition of RANKL-Induced Osteoclastogenesis
por: Li, Chang-hong, et al.
Publicado: (2021)

RANKL/RANK/OPG Pathway: A Mechanism Involved in Exercise-Induced Bone Remodeling
por: Tobeiha, Mohammad, et al.
Publicado: (2020)

TRAP5b and RANKL/OPG Predict Bone Pathology in Patients with Gaucher Disease
por: Ivanova, Margarita, et al.
Publicado: (2021)

The RANK/RANKL/OPG system and tumor bone metastasis: Potential mechanisms and therapeutic strategies
por: Zhang, Yan, et al.
Publicado: (2022)

Alendronate (ALN) combined with Osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats
por: Wang, Yan, et al.
Publicado: (2011)

Acupotomy Contributes to Suppressing Subchondral Bone Resorption in KOA Rabbits by Regulating the OPG/RANKL Signaling Pathway
por: Wang, Tong, et al.
Publicado: (2021)

Vitamin D inhibits bone loss in mice with thyrotoxicosis by activating the OPG/RANKL and Wnt/β-catenin signaling pathways
por: Xu, Dan, et al.
Publicado: (2022)

Corrigendum: Nitazoxanide, an antiprotozoal drug, reduces bone loss in ovariectomized mice by inhibition of RANKL-induced osteoclastogenesis
por: Li, Chang-hong, et al.
Publicado: (2023)

Triptolide Prevents Bone Destruction in the Collagen-Induced Arthritis Model of Rheumatoid Arthritis by Targeting RANKL/RANK/OPG Signal Pathway
por: Liu, Chunfang, et al.
Publicado: (2013)

Icariin Prevents Diabetes-Induced Bone Loss in Rats by Reducing Blood Glucose and Suppressing Bone Turnover
por: Qi, Shanshan, et al.
Publicado: (2019)

The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis
por: Weitzmann, M. Neale
Publicado: (2013)

RANK/RANKL/OPG Signaling Pathways in Necrotic Jaw Bone from Bisphosphonate-Treated Subjects
por: Nisio, C. Di, et al.
Publicado: (2015)

RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives
por: Infante, Marco, et al.
Publicado: (2019)

Regulatory Effects and Interactions of the Wnt and OPG-RANKL-RANK Signaling at the Bone-Cartilage Interface in Osteoarthritis
por: Kovács, Béla, et al.
Publicado: (2019)

Influence of Polymorphisms in the RANKL/RANK/OPG Signaling Pathway on Volumetric Bone Mineral Density and Bone Geometry at the Forearm in Men
por: Roshandel, Delnaz, et al.
Publicado: (2011)

Crataegus pinnatifida Bunge Inhibits RANKL-Induced Osteoclast Differentiation in RAW 264.7 Cells and Prevents Bone Loss in an Ovariectomized Rat Model
por: Kim, Minsun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d6a0oqr5rqutaaibia27ghrgq1